Browse diseases

…Objectives Cerebral palsy (CP) is a leading cause of childhood disability in low-income s…

…e peptide-1 (GLP-1) receptor agonists are increasingly used for metabolic disease, but their safety profile in patients with chronic pancreatitis…

…ssociated with CL/P in a Pakistani cohort.Methods Patients with CL/P were recruited from a tertiary care hospital in Faisalabad, Pak…

…ment in weight.Conclusions A dedicated joint multi-disciplinary pancreatitis clinic was set up to provide optimal care to an often overlooke…

…isual impairment is reported to affect 40%–50% of children with cerebral palsy (CP). Vision difficulties in the context of rehabilitation are …

…oids compared to those treating APOP or CP. Clinicians treating CP perceived fewer barriers and greater benefits of opioids, where…

….43 to 2.66; p=0.88), with no difference in time to recurrence. New-onset diabetes occurred in four participants receiving simvastatin, raising sa…

… in preterm labour (<30 weeks’ gestation) to reduce the risk of cerebral palsy (CP) in the preterm baby. However, the implementation of this g…

…ercentiles of the WHO growth curves with curves for people with cerebral palsy (CP) that take into account the Gross Motor Function Classifica…

…Malnutrition is a common comorbidity in children with cerebral palsy (CP), especially in low-resource settings. Feeding difficulties…

…nfant Neurological Examination (HINE) was implemented for early CP detection in TASH. A structured HINE training program was deliv…

…59; p<0.001). (IDDF2026-ABS-0326 Figure 1. Clinical outcomes in chronic pancreatitis GLP-1 RA vs control)Conclusions The use of GLP-1 receptor agoni…